Table 1 Correlation of clinicopathological findings and Met expression
From: Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma
Patient characteristics ( n =145) | Overall | Low Met expression ( N =67) | High Met expression ( N =78) | P -value |
|---|---|---|---|---|
Median age (range) | 67 (35–85) | 67 (35–83) | 68 (44–85) | 0.493 |
Sex | ||||
Male (%) | 120 (83%) | 63 (94%) | 57 (73%) | 0.435 |
Tumour characteristics | ||||
T stagea | 0.017 | |||
T1 | 44 (30%) | 29 (43%) | 15 (19%) | |
T2 | 18 (12%) | 8 (12%) | 10 (13%) | |
T3 | 83 (57%) | 30 (45%) | 53 (68%) | |
N stageb | ⩽0.001 | |||
N0 | 65 (45%) | 38 (57%) | 27 (35%) | |
N1 | 80 (55%) | 29 (43%) | 51 (65%) | |
M stagec | 0.086 | |||
M0 | 122 (84%) | 58 (87%) | 64 (82%) | |
M1a | 23 (16%) | 9 (13%) | 14 (18%) | |
Differentiation grade | 0.078 | |||
Good | 11 (8%) | 5 (7%) | 6 (8%) | |
Moderate | 56 (39%) | 35 (52%) | 21 (27%) | |
Poor | 78 (54%) | 27 (40%) | 51 (65%) | |
Overall 5-year survival | 35% | 57% | 16% | ⩽0.001 |
Disease-specific 5-year survival | 48% | 66% | 33% | ⩽0.001 |
